A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/22 (2006.01) A61K 38/17 (2006.01) C07K 14/575 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2075833
A method and medicaments for inhibition of abnormal postnatal ocular growth are disclosed. The method for inhibition of abnormal postnatal ocular growth comprises administering to the eye of an animal effective amount of VIP, PHI or analogue of these peptides. The medicaments of the invention comprise therapeutically effective amounts of a compound selected from the group consisting of vasoactive intestinal peptide, PHI and ocular growth inhibiting analogues of vasoactive intestinal peptide and PHI.
Laties Alan M.
Stone Richard A.
Gowling Lafleur Henderson Llp
The Trustees Of The University Of Pennsylvania
LandOfFree
Neuropeptide control of ocular growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuropeptide control of ocular growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuropeptide control of ocular growth will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2090148